• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats.

作者信息

Benjamin D, Grant E R, Pohorecky L A

机构信息

Center of Alcohol Studies, Rutgers University, New Brunswick, NJ 08855.

出版信息

Brain Res. 1993 Sep 3;621(1):137-40. doi: 10.1016/0006-8993(93)90309-b.

DOI:10.1016/0006-8993(93)90309-b
PMID:7693299
Abstract

The effect of the opioid receptor antagonist, naltrexone, on ethanol-induced changes in extracellular dopamine and serotonin in the nucleus accumbens was investigated using in vivo microdialysis in awake, freely moving rats. Locally applied ethanol (5% infused transprobe) resulted in substantial increases in dopamine in dialysate. Administration of naltrexone (cumulative dosing with 0.25-1.0 mg/kg i.p.) during ethanol administration dose-dependently reversed ethanol-induced increases in extracellular dopamine and its metabolite homovanillic acid but not serotonin. These data demonstrate an essential role for the endogenous opioid system in stimulation of dopamine release by ethanol in a brain area associated with reward and support the opioid system as a prime target for pharmacological modulation of the rewarding effects and consumption of ethanol.

摘要

相似文献

1
Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats.
Brain Res. 1993 Sep 3;621(1):137-40. doi: 10.1016/0006-8993(93)90309-b.
2
Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.伏隔核中δ-阿片受体的阻断可防止乙醇诱导的多巴胺释放刺激。
Eur J Pharmacol. 1993 Jan 12;230(2):239-41. doi: 10.1016/0014-2999(93)90809-v.
3
Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system.纳曲酮对乙醇诱导的大鼠中枢多巴胺能系统变化的影响。
Alcohol Alcohol. 2005 Jul-Aug;40(4):297-301. doi: 10.1093/alcalc/agh163. Epub 2005 May 16.
4
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.纳曲酮对乙醇强化行为的抑制作用与乙醇诱导的伏隔核透析液多巴胺水平升高的减弱有关。
J Neurosci. 1998 Dec 15;18(24):10663-71. doi: 10.1523/JNEUROSCI.18-24-10663.1998.
5
Effect of ethanol on extracellular dopamine in the nucleus accumbens of alcohol-preferring AA and alcohol-avoiding ANA rats.乙醇对偏爱酒精的AA大鼠和回避酒精的ANA大鼠伏隔核细胞外多巴胺的影响。
Pharmacol Biochem Behav. 1995 Sep;52(1):29-34. doi: 10.1016/0091-3057(95)00097-g.
6
Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.强啡肽II通过非阿片受体依赖机制提高伏隔核中多巴胺的细胞外水平。
Eur J Pharmacol. 2004 Apr 26;491(1):31-6. doi: 10.1016/j.ejphar.2004.03.028.
7
Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.μ-阿片受体和δ-阿片受体之间的相互作用,尤其是假定的δ1-阿片受体和δ2-阿片受体之间的相互作用,促进伏隔核中的多巴胺释放。
Neuroscience. 2005;135(1):213-25. doi: 10.1016/j.neuroscience.2005.03.065.
8
Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.通过微透析测量,注入伏隔核的苯环己哌啶(PCP)会增加细胞外多巴胺和血清素的水平。
Life Sci. 1988;42(18):1713-23. doi: 10.1016/0024-3205(88)90037-9.
9
Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens.酒精会刺激伏隔核中多巴胺和血清素的释放。
Alcohol. 1992 Jan-Feb;9(1):17-22. doi: 10.1016/0741-8329(92)90004-t.
10
Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.δ-阿片受体拮抗剂和μ-阿片受体拮抗剂对苯丙胺诱导的纹状体和伏隔核细胞外多巴胺增加的不同作用。
J Neurochem. 1996 Dec;67(6):2292-9. doi: 10.1046/j.1471-4159.1996.67062292.x.

引用本文的文献

1
Group singing and its effect on cortisol, alpha amylase, oxytocin, and pain threshold in patients with Parkinson's disease.合唱及其对帕金森病患者皮质醇、α淀粉酶、催产素和痛阈的影响。
Front Neurosci. 2025 May 9;19:1569601. doi: 10.3389/fnins.2025.1569601. eCollection 2025.
2
Beyond mediators: A critical review and methodological path forward for studying mechanisms in alcohol use treatment research.超越中介因素:酒精使用治疗研究中机制研究的批判性综述与方法学前进路径
Alcohol Clin Exp Res (Hoboken). 2024 Feb;48(2):215-229. doi: 10.1111/acer.15242. Epub 2023 Dec 27.
3
Effects of dopamine D2/3 and opioid receptor antagonism on the trade-off between model-based and model-free behaviour in healthy volunteers.
多巴胺 D2/3 受体和阿片受体拮抗作用对健康志愿者基于模型和非基于模型行为之间权衡的影响。
Elife. 2022 Dec 5;11:e79661. doi: 10.7554/eLife.79661.
4
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial.阿片受体拮抗剂纳曲酮治疗酒精使用障碍患者减少重度饮酒的疗效的表观遗传调节剂:一项随机试验。
Pharmacogenomics J. 2022 Feb;22(1):1-8. doi: 10.1038/s41397-021-00250-8. Epub 2021 Aug 11.
5
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.伐尼克兰与纳曲酮联合使用可减弱重度饮酒吸烟者对酒精线索的激活。
Drug Alcohol Depend. 2021 Aug 1;225:108825. doi: 10.1016/j.drugalcdep.2021.108825. Epub 2021 Jun 23.
6
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?妊娠期酒精使用障碍的药物治疗:是时候重新考虑了吗?
Drugs. 2021 May;81(7):739-748. doi: 10.1007/s40265-021-01509-x. Epub 2021 Apr 8.
7
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.肝细胞癌预防的风险因素、发病机制及策略:重点关注二级预防及其转化挑战
J Clin Med. 2020 Nov 25;9(12):3817. doi: 10.3390/jcm9123817.
8
Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.Sigma 受体诱导大鼠过度饮酒:阿片受体系统的调制。
Pharmacol Biochem Behav. 2020 May;192:172914. doi: 10.1016/j.pbb.2020.172914. Epub 2020 Mar 20.
9
Pharmacotherapeutic management of co-morbid alcohol and opioid use.共病酒精和阿片类药物使用的药物治疗管理。
Expert Opin Pharmacother. 2020 May;21(7):823-839. doi: 10.1080/14656566.2020.1732349. Epub 2020 Feb 27.
10
Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.快感缺失作为阿片类物质使用障碍维持和治疗中的关键临床特征。
Clin Psychol Sci. 2019 Nov;7(6):1190-1206. doi: 10.1177/2167702619855659. Epub 2019 Sep 23.